Autoantibodies directed against insulin receptor during the course of Castleman disease: a new case reaffirming autoimmune hypoglycemia as a relapse warning signal

Xavier Jannot, Martine Auclair, Martin Martinot, Amin Maazouzi, David Boutboul, Corinne Vigouroux, Yannick Dieudonné

Open source

DOI
10.12890/2025_005355
Published
4
Container
European Journal of Case Reports in Internal Medicine
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.12890/2025_005355,
  title = {Autoantibodies directed against insulin receptor during the course of Castleman disease: a new case reaffirming autoimmune hypoglycemia as a relapse warning signal},
  author = {Xavier Jannot and Martine Auclair and Martin Martinot and Amin Maazouzi and David Boutboul and Corinne Vigouroux and Yannick Dieudonné},
  year = {2025},
  journal = {European Journal of Case Reports in Internal Medicine},
  doi = {10.12890/2025_005355},
  url = {https://doi.org/10.12890/2025_005355}
}

RIS

TY  - JOUR
TI  - Autoantibodies directed against insulin receptor during the course of Castleman disease: a new case reaffirming autoimmune hypoglycemia as a relapse warning signal
AU  - Xavier Jannot
AU  - Martine Auclair
AU  - Martin Martinot
AU  - Amin Maazouzi
AU  - David Boutboul
AU  - Corinne Vigouroux
AU  - Yannick Dieudonné
PY  - 2025
JO  - European Journal of Case Reports in Internal Medicine
DO  - 10.12890/2025_005355
UR  - https://doi.org/10.12890/2025_005355
ER  - 

APA

Jannot, X., Auclair, M., Martinot, M., Maazouzi, A., Boutboul, D., Vigouroux, C., & Dieudonné, Y. (2025). Autoantibodies directed against insulin receptor during the course of Castleman disease: a new case reaffirming autoimmune hypoglycemia as a relapse warning signal. European Journal of Case Reports in Internal Medicine. https://doi.org/10.12890/2025_005355

Source records